Standards and pitfalls of focal ischemia models in spontaneously hypertensive rats: With a systematic review of recent articles

Journal of Translational Medicine

Volumn 10, Issue 1, 2012, Pages

  Yao, Hiroshi ^a   Nabika, Toru ^b  

^a National Hospital Organization Hizen Psychiatric Center   (Japan)

^b SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

Author keywords

Animal Models; Cerebrovascular disease; Experimental; Focal ischemia; Genetics; Hypertension; Stroke

Indexed keywords

BLOOD CLOT LYSIS; BLOOD CLOTTING; BRAIN BLOOD FLOW; BRAIN INFARCTION; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CLINICAL DATA REPOSITORY; DIFFUSION WEIGHTED IMAGING; GENETIC HETEROGENEITY; GENETIC MARKER; HYPERTENSION; METHODOLOGY; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NONHUMAN; QUALITY CONTROL; REVIEW; SALT LOADING; SEQUENCE HOMOLOGY; SPONTANEOUSLY HYPERTENSIVE RAT; STROKE PRONE SPONTANEOUSLY HYPERTENSIVE RAT; SYSTEMATIC REVIEW;

ANIMALS; BRAIN ISCHEMIA; CEREBROVASCULAR CIRCULATION; DISEASE MODELS, ANIMAL; HUMANS; INFARCTION, MIDDLE CEREBRAL ARTERY; RATS; RATS, INBRED SHR; STROKE;

EID: 84863470227     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-10-139     Document Type: Review

References (87)

1. Okamoto K, Aoki K. Development of a strain of spontaneously hypertensive rats. Jpn Circ J 1963, 27:282-293. 10.1253/jcj.27.282, 13939773.
2. Okamoto K, Yamori Y, Nagaoka A. Establishment of the stroke-prone spontaneously hypertensive rat. Circ Res 1974, 34/35:I143-I153.
3. Jacewicz M, Tanabe J, Pulsinelli WA. The CBF threshold and dynamics for focal cerebral infarction in spontaneously hypertensive rats. J Cereb Blood Flow Metab 1992, 12:359-370. 10.1038/jcbfm.1992.53, 1569133.
4. Kaplan B, Brint S, Tanabe J, Jacewicz M, Wang XJ, Pulsinelli W. Temporal thresholds for neocortical infarction in rats subjected to reversible focal cerebral ischemia. Stroke 1991, 22:1032-1039. 10.1161/01.STR.22.8.1032, 1866750.
5. Nabika T, Nara Y, Ikeda K, Endo J, Yamori Y. Genetic heterogeneity of the spontaneously hypertensive rat. Hypertension 1991, 18:12-16. 10.1161/01.HYP.18.1.12, 1860707.
6. St Lezin E, Simonet L, Pravenec M, Kurtz TW. Hypertensive strains and normotensive 'control' strains. How closely are they related?. Hypertension 1992, 19:419-424. 10.1161/01.HYP.19.5.419, 1568758.
7. Johnson ML, Ely DL, Turner ME. Genetic divergence between the Wistar-Kyoto rat and the spontaneously hypertensive rat. Hypertension 1992, 19:425-427. 10.1161/01.HYP.19.5.425, 1349001.
8. Yamori Y, Horie R, Handa H, Sato M, Fukase M. Pathogenetic similarity of strokes in stroke-prone spontaneously hypertensive rats and humans. Stroke 1976, 7:46-53. 10.1161/01.STR.7.1.46, 1258104.
9. Bailey EL, Smith C, Sudlow CL, Wardlaw JM. Is the spontaneously hypertensive stroke prone rat a pertinent model of sub cortical ischemic stroke? A systematic review. Int J Stroke. 2011, 6:434-444. 10.1111/j.1747-4949.2011.00659.x, 21951409.
10. Hainsworth AH, Markus HS. Do in vivo experimental models reflect human cerebral small vessel disease? A systematic review. J Cereb Blood Flow Metab 2008, 28:1877-1891. 10.1038/jcbfm.2008.91, 18698331.
11. Nabika T, Cui Z, Masuda J. The stroke-prone spontaneously hypertensive rat: how good is it as a model for cerebrovascular diseases?. Cell Mol Neurobiol 2004, 24:639-646.
12. Rubattu S, Hubner N, Ganten U, Evangelista A, Stanzione R, Di Angelantonio E, Plehm R, Langanki R, Gianazza E, Sironi L, D'Amati G, Volpe M. Reciprocal congenic lines for a major stroke QTL on rat chromosome 1. Physiol Genomics 2006, 27:108-113. 10.1152/physiolgenomics.00086.2006, 16835352.
13. Tamura A, Graham DI, McCulloch J, Teasdale GM. Focal cerebral ischaemia in the rat: 1. Description of technique and early neuropathological consequences following middle cerebral artery occlusion. J Cereb Blood Flow Metab 1981, 1:53-60. 10.1038/jcbfm.1981.6, 7328138.
14. Coyle P, Jokelainen PT. Differential outcome to middle cerebral artery occlusion in spontaneously hypertensive stroke-prone rats (SHRSP) and Wistar Kyoto (WKY) rats. Stroke 1983, 14:605-611. 10.1161/01.STR.14.4.605, 6658939.
15. Duverger D, MacKenzie ET. The quantification of cerebral infarction following focal ischemia in the rat: influence of strain, arterial pressure, blood glucose concentration, and age. J Cereb Blood Flow Metab 1988, 8:449-461. 10.1038/jcbfm.1988.86, 2968987.
16. Brint S, Jacewicz M, Kiessling M, Tanabe J, Pulsinelli W. Focal brain ischemia in the rat: methods for reproducible neocortical infarction using tandem occlusion of the distal middle cerebral and ipsilateral common carotid arteries. J Cereb Blood Flow Metab 1988, 8:474-485. 10.1038/jcbfm.1988.88, 3392112.
17. Yao H, Sugimori H, Fukuda K, Takada J, Ooboshi H, Kitazono T, Ibayashi S, Iida M. Photothrombotic middle cerebral artery occlusion and reperfusion laser system in spontaneously hypertensive rats. Stroke 2003, 34:2716-2721. 10.1161/01.STR.0000094730.38343.73, 14576380.
18. Astrup J, Siesjö BK, Symon L. Thresholds in cerebral ischemia - the ischemic penumbra. Stroke 1981, 12:723-725. 10.1161/01.STR.12.6.723, 6272455.
19. Furspan PB, Rinaldi GJ, Hoffman K, Bohr DF. Dietary calcium and cell membrane abnormality in genetic hypertension. Hypertension 1989, 13:727-730. 10.1161/01.HYP.13.6.727, 2737718.
20. Fujii K, Weno BL, Baumbach GL, Heistad DD. Effect of antihypertensive treatment on focal cerebral infarction. Hypertension 1992, 19:713-716. 10.1161/01.HYP.19.6.713, 1534316.
21. Watson BD, Dietrich WD, Busto R, Wachtel MS, Ginsberg MD. Induction of reproducible brain infarction by photochemically initiated thrombosis. Ann Neurol 1985, 17:497-504. 10.1002/ana.410170513, 4004172.
22. Prado R, Watson BD, Zhao W, Yao H, Busto R, Dietrich WD, Ginsberg MD. L-arginine does not improve cortical perfusion or histopathological outcome in spontaneously hypertensive rats subjected to distal middle cerebral artery photothrombotic occlusion. J Cereb Blood Flow Metab 1996, 16:612-22.
23. Yao H, Ibayashi S, Sugimori H, Fujii K, Fujishima M. Simplified model of krypton laser-induced thrombotic distal middle cerebral artery occlusion in spontaneously hypertensive rats. Stroke 1996, 27:333-336. 10.1161/01.STR.27.2.333, 8571433.
24. Cai H, Yao H, Ibayashi S, Uchimura H, Fujishima M. Photothrombotic middle cerebral artery occlusion in spontaneously hypertensive rats: influence of substrain, gender, and distal middle cerebral artery patterns on infarct size. Stroke 1998, 29:1982-1986. 10.1161/01.STR.29.9.1982, 9731627.
25. Ogata J, Fujishima M, Morotomi Y, Omae T. Cerebral infarction following bilateral carotid artery ligation in normotensive and spontaneously hypertensive rats: a pathological study. Stroke 1976, 7:54-60. 10.1161/01.STR.7.1.54, 1258105.
26. Watson BD, Prado R, Veloso A, Brunschwig JP, Dietrich WD. Cerebral blood flow restoration and reperfusion injury after ultraviolet laser-facilitated middle cerebral artery recanalization in rat thrombotic stroke. Stroke 2002, 33:428-434. 10.1161/hs0202.102730, 11823647.
27. Yao H, Nabika T. Characterizing photothrombotic distal middle cerebral artery occlusion and YAG laser-induced reperfusion model in the Izumo strain of spontaneously hypertensive rats. Cell Mol Neurobiol 2011, 31:57-63. 10.1007/s10571-010-9553-5, 20703797.
28. Koizumi J, Yoshida Y, Nakazawa T, Ooneda G. Experimental studies of ischemic brain edema. I: a new experimental model of cerebral embolism in rats in which recirculation can be introdued in the ischemic area. Jpn J Stroke 1986, 8:1-8.
29. Longa EZ, Weinstein PR, Carlson S, Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 1989, 20:84-91. 10.1161/01.STR.20.1.84, 2643202.
30. Howells DW, Porritt MJ, Rewell SS, O'Collins V, Sena ES, van der Worp HB, Traystman RJ, Macleod MR. Different strokes for different folks: the rich diversity of animal models of focal cerebral ischemia. J Cereb Blood Flow Metab 2010, 30:1412-1431. 10.1038/jcbfm.2010.66, 2949237,2949237, 20485296.
31. Kawamura S, Li Y, Shirasawa M, Yasui N, Fukasawa H. Protective effect of nilvadipine on focal cerebral ischemia in spontaneously hypertensive rats. Neurol Med Chir (Tokyo) 1996, 36:151-155.
32. Alkayed NJ, Harukuni I, Kimes AS, London ED, Traystman RJ, Hurn PD. Gender-linked brain injury in experimental stroke. Stroke 1998, 29:159-165. 10.1161/01.STR.29.1.159, 9445346.
33. Lakhan SE, Kirchgessner A, Hofer M. Inflammatory mechanisms in ischemic stroke: therapeutic approaches. J Transl Med 2009, 7:7-97. 10.1186/1479-5876-7-7, 2630935, 19146667.
34. Kanemitsu H, Nakagomi T, Tamura A, Tsuchiya T, Kono G, Sano K. Differences in the extent of primary ischemic damage between middle cerebral artery coagulation and intraluminal occlusion models. J Cereb Blood Flow Metab 2002, 22:1196-1204.
35. Henning EC, Latour LL, Hallenbeck JM, Warach S. Reperfusion-associated hemorrhagic transformation in SHR rats: evidence of symptomatic parenchymal hematoma. Stroke 2008, 39:3405-3410. 10.1161/STROKEAHA.108.520304, 18757286.
36. Guan W, Kozak A, Fagan SC. Drug repurposing for vascular protection after acute ischemic stroke. Acta Neurochir Suppl 2011, 111:295-298. 10.1007/978-3-7091-0693-8_49, 3166853, 21725771.
37. Yamashita T, Kamiya T, Deguchi K, Inaba T, Zhang H, Shang J, Miyazaki K, Ohtsuka A, Katayama Y, Abe K. Dissociation and protection of the neurovascular unit after thrombolysis and reperfusion in ischemic rat brain. J Cereb Blood Flow Metab 2009, 29:715-725. 10.1038/jcbfm.2008.164, 19142198.
38. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995, 333:1581-1587. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group.
39. Hacke W, Kaste M, Bluhmki E, Brozman M, Dávalos A, Guidetti D, Larrue V, Lees KR, Medeghri Z, Machnig T, Schneider D, von Kummer R, Wahlgren N, Toni D. ECASS Investigators: Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008, 359:1317-1329. 10.1056/NEJMoa0804656, 18815396.
40. Wahlgren N, Ahmed N, Eriksson N, Aichner F, Bluhmki E, Dávalos A, Erilä T, Ford GA, Grond M, Hacke W, Hennerici MG, Kaste M, Köhrmann M, Larrue V, Lees KR, Machnig T, Roine RO, Toni D, Vanhooren G. Safe Implementation of Thrombolysis in Stroke-MOnitoring STudy Investigators: Multivariable analysis of outcome predictors and adjustment of main outcome results to baseline data profile in randomized controlled trials: Safe Implementation of Thrombolysis in Stroke-MOnitoring STudy (SITS-MOST). Stroke 2008, 39:3316-3322. 10.1161/STROKEAHA.107.510768, 18927461.
41. Asahi M, Asahi K, Wang X, Lo EH. Reduction of tissue plasminogen activator-induced hemorrhage and brain injury by free radical spin trapping after embolic focal cerebral ischemia in rats. J Cereb Blood Flow Metab 2000, 20:452-457.
42. Tejima E, Katayama Y, Suzuki Y, Kano T, Lo EH. Hemorrhagic transformation after fibrinolysis with tissue plasminogen activator: evaluation of role of hypertension with rat thromboembolic stroke model. Stroke 2001, 32:1336-1340. 10.1161/01.STR.32.6.1336, 11387496.
43. Sun L, Zhou W, Mueller C, Sommer C, Heiland S, Bauer AT, Marti HH, Veltkamp R. Oxygen therapy reduces secondary hemorrhage after thrombolysis in thromboembolic cerebral ischemia. J Cereb Blood Flow Metab 2010, 30:1651-1660. 10.1038/jcbfm.2010.50, 2949252, 20424638.
44. Fujiwara N, Murata Y, Arai K, Egi Y, Lu J, Wu O, Singhal AB, Lo EH. Combination therapy with normobaric oxygen (NBO) plus thrombolysis in experimental ischemic stroke. BMC Neurosci 2009, 10:79. 10.1186/1471-2202-10-79, 2714858, 19604385.
45. Astrup J, Symon L, Branston NM, Lassen NA. Cortical evoked potential and extracellular K+ and H+ at critical levels of brain ischemia. Stroke 1977, 8:51-57. 10.1161/01.STR.8.1.51, 13521.
46. Zhao W, Belayev L, Ginsberg MD. Transient middle cerebral artery occlusion by intraluminal suture: II. Neurological deficits, and pixel-based correlation of histopathology with local blood flow and glucose utilization. J Cereb Blood Flow Metab 1997, 17:1281-1290.
47. Hossmann KA. Viability thresholds and the penumbra of focal ischemia. Ann Neurol 1994, 36:557-565. 10.1002/ana.410360404, 7944288.
48. Sun PZ, Zhou J, Sun W, Huang J, van Zijl PC. Detection of the ischemic penumbra using pH-weighted MRI. J Cereb Blood Flow Metab 2007, 27:1129-1136. 10.1038/sj.jcbfm.9600424, 17133226.
49. Heiss WD. The ischemic penumbra: correlates in imaging and implications for treatment of ischemic stroke. The Johann Jacob Wepfer award 2011. Cerebrovasc Dis 2011, 32:307-320. 10.1159/000330462, 21921593.
50. Campbell BC, Purushotham A, Christensen S, Desmond PM, Nagakane Y, Parsons MW, Lansberg MG, Mlynash M, Straka M, De Silva DA, Olivot JM, Bammer R, Albers GW, Donnan GA, Davis SM. The infarct core is well represented by the acute diffusion lesion: sustained reversal is infrequent. J Cereb Blood Flow Metab 2012, 32:50-56. 10.1038/jcbfm.2011.102, 3323290, 21772309.
51. Jones SC, Kharlamov A, Yanovski B, Kim DK, Easley KA, Yushmanov VE, Ziolko SK, Boada FE. Stroke onset time using sodium MRI in rat focal cerebral ischemia. Stroke 2006, 37:883-888. 10.1161/01.STR.0000198845.79254.0f, 16424376.
52. De Silva DA, Brekenfeld C, Ebinger M, Christensen S, Barber PA, Butcher KS, Levi CR, Parsons MW, Bladin CF, Donnan GA, Davis SM. Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET) Investigators: The benefits of intravenous thrombolysis relate to the site of baseline arterial occlusion in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET). Stroke 2010, 41:295-299. 10.1161/STROKEAHA.109.562827, 20056931.
53. Letourneur A, Roussel S, Toutain J, Bernaudin M, Touzani O. Impact of genetic and renovascular chronic arterial hypertension on the acute spatiotemporal evolution of the ischemic penumbra: a sequential study with MRI in the rat. J Cereb Blood Flow Metab 2011, 31:504-513. 10.1038/jcbfm.2010.118, 3049506, 20648035.
54. Yao H, Okada Y, Ibayashi S. Therapeutic time window for YAG laser-induced reperfusion of thrombotic stroke in hypertensive rats. Neuroreport 2002, 13:1005-1008. 10.1097/00001756-200206120-00004, 12060796.
55. Liszczak TM, Hedley-Whyte ET, Adams JF, Han DH, Kolluri VS, Vacanti FX, Heros RC, Zervas NT. Limitations of tetrazolium salts in delineating infarcted brain. Acta Neuropathol 1984, 65:150-157. 10.1007/BF00690469, 6084391.
56. Zille M, Farr TD, Przesdzing I, Müller J, Sommer C, Dirnagl U, Wunder A. Visualizing cell death in experimental focal cerebral ischemia: promises, problems, and perspectives. J Cereb Blood Flow Metab. 2012, 32:213-231. 10.1038/jcbfm.2011.150, 3272608, 22086195.
57. Yao H, Yoshii N, Akira T, Nakahara T. Reperfusion-induced temporary appearance of therapeutic window in penumbra after 2 h of photothrombotic middle cerebral artery occlusion in rats. J Cereb Blood Flow Metab 2009, 29:565-574. 10.1038/jcbfm.2008.147, 19088742.
58. Yao H, Takasawa R, Fukuda K, Shiokawa D, Sadanaga-Akiyoshi F, Ibayashi S, Tanuma S, Uchimura H. DNA fragmentation in ischemic core and penumbra in focal cerebral ischemia in rats. Brain Res Mol Brain Res 2001, 91:112-118. 10.1016/S0169-328X(01)00135-8, 11457498.
59. Yao H, Nakahara T, Nakagawa N, Hashimoto K, Kuroki T. Regional and temporal changes in proteomic profile after middle cerebral artery occlusion with or without reperfusion in rats. Neurochem Res 2009, 34:1999-2007. 10.1007/s11064-009-9988-6, 19444605.
60. Braeuninger S, Kleinschnitz C. Rodent models of focal cerebral ischemia: procedural pitfalls and translational problems. Exp Transl Stroke Med 2009, 25:1-8.
61. Dirnagl U, Pulsinelli W. Autoregulation of cerebral blood flow in experimental focal brain ischemia. J Cereb Blood Flow Metab 1990, 10:327-336. 10.1038/jcbfm.1990.61, 2329121.
62. Zhu CZ, Auer RN. Graded hypotension and MCA occlusion duration: effect in transient focal ischemia. J Cereb Blood Flow Metab 1995, 15:980-988. 10.1038/jcbfm.1995.124, 7593359.
63. Zausinger S, Baethmann A, Schmid-Elsaesser R. Anesthetic methods in rats determine outcome after experimental focal cerebral ischemia: mechanical ventilation is required to obtain controlled experimental conditions. Brain Res Brain Res Protoc 2002, 9:112-121. 10.1016/S1385-299X(02)00138-1, 12034330.
64. Yao H, Matsumoto T, Hirano M, Kuroki T, Tsutsumi T, Uchimura H, Nakamura K, Nakahara T, Fujishima M. Involvement of brain stem noradrenergic neurons in the development of hypertension in spontaneously hypertensive rats. Neurochem Res 1989, 14:75-79. 10.1007/BF00969761, 2710280.
65. Mori S, Kato M, Fujishima M. Impaired maze learning and cerebral glucose utilization in aged hypertensive rats. Hypertension 1995, 25:545-553. 10.1161/01.HYP.25.4.545, 7721396.
66. Yao H, Cui ZH, Masuda J, Nabika T. Congenic removal of a QTL for blood pressure attenuates infarct size produced by middle cerebral artery occlusion in hypertensive rats. Physiol Genomics 2007, 30:69-73. 10.1152/physiolgenomics.00149.2006, 17327494.
67. DeBow SB, Clark DL, MacLellan CL, Colbourne F. Incomplete assessment of experimental cytoprotectants in rodent ischemia studies. Can J Neurol Sci. 2003, 30:368-374.
68. Hurn PD, Vannucci SJ, Hagberg H. Adult or perinatal brain injury: does sex matter?. Stroke 2005, 36:193-195. 10.1161/01.STR.0000153064.41332.f6, 15625289.
69. Fukuda K, Yao H, Ibayashi S, Nakahara T, Uchimura H, Fujishima M. Ovariectomy exacerbates and estrogen replacement attenuates photothrombotic focal ischemic brain injury in rats. Stroke 2000, 31:155-160. 10.1161/01.STR.31.1.155, 10625732.
70. Macleod MR, O'Collins T, Howells DW, Donnan GA. Pooling of animal experimental data reveals influence of study design and publication bias. Stroke 2004, 35:1203-1208. 10.1161/01.STR.0000125719.25853.20, 15060322.
71. Stroke Therapy Academic Industry Roundtable (STAIR) Recommendations for Standards Regarding Preclinical Neuroprotective and Restorative Drug Development. Stroke 1999, 30:2752-2758. Stroke Therapy Academic Industry Roundtable (STAIR).
72. Macleod MR, O'Collins T, Horky LL, Howells DW, Donnan GA. Systematic review and metaanalysis of the efficacy of FK506 in experimental stroke. J Cereb Blood Flow Metab 2005, 25:713-721. 10.1038/sj.jcbfm.9600064, 15703698.
73. O'Collins VE, Macleod MR, Donnan GA, Horky LL, van der Worp BH, Howells DW. 1,026 experimental treatments in acute stroke. Ann Neurol 2006, 59:467-477. 10.1002/ana.20741, 16453316.
74. Sandset EC, Bath PM, Boysen G, Jatuzis D, Kõrv J, Lüders S, Murray GD, Richter PS, Roine RO, Terént A, Thijs V. Berge E; SCAST Study Group: The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial. Lancet 2011, 377:741-750. 10.1016/S0140-6736(11)60104-9, 21316752.
75. Kozak W, Kozak A, Johnson MH, Elewa HF, Fagan SC. Vascular protection with candesartan after experimental acute stroke in hypertensive rats: a dose-response study. J Pharmacol Exp Ther 2008, 326:773-782. 10.1124/jpet.108.139618, 18559971.
76. McCabe C, Gallagher L, Gsell W, Graham D, Dominiczak AF, Macrae IM. Differences in the evolution of the ischemic penumbra in stroke-prone spontaneously hypertensive and Wistar-Kyoto rats. Stroke. 2009, 40:3864-3868. 10.1161/STROKEAHA.109.559021, 3145096, 19797186.
77. Dijkhuizen RM, Asahi M, Wu O, Rosen BR, Lo EH. Rapid breakdown of microvascular barriers and subsequent hemorrhagic transformation after delayed recombinant tissue plasminogen activator treatment in a rat embolic stroke model. Stroke. 2002, 33:2100-2104. 10.1161/01.STR.0000023534.37670.F7, 12154270.
78. Riyamongkol P, Zhao W, Liu Y, Belayev L, Busto R, Ginsberg MD. Automated registration of laser Doppler perfusion images by an adaptive correlation approach: application to focal cerebral ischemia in the rat. J Neurosci Methods 2002, 122:79-90. 10.1016/S0165-0270(02)00294-7, 12535767.
79. Ren Y, Hashimoto M, Pulsinelli WA, Nowak TS. Hypothermic protection in rat focal ischemia models: strain differences and relevance to "reperfusion injury". J Cereb Blood Flow Metab 2004, 24:42-53.
80. Serikawa T, Mashimo T, Takizawa A, Okajima R, Maedomari N, Kumafuji K, Tagami F, Neoda Y, Otsuki M, Nakanishi S, Yamasaki K, Voigt B, Kuramoto T. National BioResource Project-Rat and related activities. Exp Anim 2009, 58:333-341. 10.1538/expanim.58.333, 19654430.
81. Mashimo T, Voigt B, Tsurumi T, Naoi K, Nakanishi S, Yamasaki K, Kuramoto T, Serikawa T. A set of highly informative rat simple sequence length polymorphism (SSLP) markers and genetically defined rat strains. BMC Genet 2006, 7:19. 1475628, 16584579.
82. Jeffs B, Clark JS, Anderson NH, Gratton J, Brosnan MJ, Gauguier D, Reid JL, Macrae IM, Dominiczak AF. Sensitivity to cerebral ischaemic insult in a rat model of stroke is determined by a single genetic locus. Nat Genet 1997, 16:364-367. 10.1038/ng0897-364, 9241273.
83. Mashimo T, Takizawa A, Voigt B, Yoshimi K, Hiai H, Kuramoto T, Serikawa T. Generation of knockout rats with X-linked severe combined immunodeficiency (X-SCID) using zinc-finger nucleases. PLoS One 2010, 5:e8870. 10.1371/journal.pone.0008870, 2810328, 20111598.
84. Rubattu S, Gigante B, Stanzione R, De Paolis P, Tarasi D, Volpe M. In the search for stroke genes: a long and winding road. Am J Hypertens 2004, 17:197-202. 10.1016/j.amjhyper.2003.10.011, 14751665.
85. Carr FJ, McBride MW, Carswell HV, Graham D, Strahorn P, Clark JS, Charchar FJ, Dominiczak AF. Genetic aspects of stroke: human and experimental studies. J Cereb Blood Flow Metab 2002, 22:767-773.
86. Graham D, McBride MW, Gaasenbeek M, Gilday K, Beattie E, Miller WH, McClure JD, Polke JM, Montezano A, Touyz RM, Dominiczak AF. Candidate genes that determine response to salt in the stroke-prone spontaneously hypertensive rat: congenic analysis. Hypertension 2007, 50:1134-1141. 10.1161/HYPERTENSIONAHA.107.095349, 17938382.
87. Aitman TJ, Glazier AM, Wallace CA, Cooper LD, Norsworthy PJ, Wahid FN, Al-Majali KM, Trembling PM, Mann CJ, Shoulders CC, Graf D, St Lezin E, Kurtz TW, Kren V, Pravenec M, Ibrahimi A, Abumrad NA, Stanton LW, Scott J. Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats. Nat Genet 1999, 21:76-83. 10.1038/5013, 9916795.